Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Onion-shaped white matter disease?
[Multiple sclerosis and occupational exposures: results of an explorative study].
Mean upper cervical cord area (MUCCA) measurement in long-standing multiple sclerosis: Relation to brain findings and clinical disability.
Self-reports of executive functioning in multiple sclerosis: to trust or not to trust.
A Review of the Psychometric Properties of Generic Utility Measures in Multiple Sclerosis.
Mesenchymal stem cells inhibit lipopolysaccharide-induced inflammatory responses of BV2 microglial cells through TSG-6.
Measures of aging with disability in U.S. secondary data sets: Results of a scoping review.
Preferences of Patients With Multiple Sclerosis for Attributes of Disease Modifying Drugs In Decision-Making: A Nominal Group Technique And Best-Worst Scaling.
Nanoparticle-Based and Bioengineered Probes and Sensors to Detect Physiological and Pathological Biomarkers in Neural Cells.
FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosis.
Current and emerging therapies for the treatment of multiple sclerosis: focus on cladribine.
Evaluation of Cytokines in Multiple Sclerosis Patients Treated with Mesenchymal Stem Cells.
Fingolimod efficacy in multiple sclerosis associated with Sjogren syndrome.
Mechanical energy expenditure of subject with multiple sclerosis engaged in daily activities: a case study.
Neurodegeneration progresses despite complete elimination of clinical relapses in a mouse model of multiple sclerosis.
Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis.
Patient education programme on immunotherapy in multiple sclerosis (PEPIMS): A controlled rater-blinded study.
Emerging stem cell therapies: treatment, safety, and biology.
Is there an increased risk of hip fracture in multiple sclerosis? Analysis of the Nationwide Inpatient Sample.
Gender influence on schizophrenia-relevant abnormalities in a cuprizone demyelination model.
Antibodies to neural and non-neural autoantigens in Japanese patients with CNS demyelinating disorders.
An exploration of impaired walking dynamics and fatigue in Multiple Sclerosis.
Immunoglobulin GM allotypes in multiple sclerosis.
Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution.
Effect of passive whole-body heating on central conduction and cortical excitability in multiple sclerosis patients and healthy controls.
Pages
« first
‹ previous
…
517
518
519
520
521
522
523
524
525
…
next ›
last »